The aim of this review is to provide an overview of the potential use of cannabinoids in the treatment of glaucoma. - GreenMedInfo Summary
n/a
Abstract Title:
[Should ophtalmologists recommend medical cannabis to patients with glaucoma?]
Abstract Source:
Ugeskr Laeger. 2018 Jul 16 ;180(29). PMID: 30020072
Article Affiliation:
Zaynab Ahmad Mouhammad
Abstract:
Cannabis has been widely used for various medical purposes since before year 2000 BC. Its effects are mediated by cannabinoids and stimulation of mainly G-protein coupled cannabinoid receptors. In 1971, subjects who smoked marihuana, showed a decrease in the intraocular pressure. Later investigations additionally revealed a neuroprotective effect of both∆-9-tetrahydrocannabinol and cannabidiol (CBD). Furthermore, CBD was found to promote neurogenesis. The aim of this review is to provide an overview of the potential use of cannabinoids in the treatment of glaucoma.
Article Published Date : Jul 15, 2018
Study Type : Review
Additional Links
Substances : Cannabidiol : CK(2644) : AC(774), Cannabinoids : CK(2052) : AC(692), Delta-tetrahydrocannabinol (THC) : CK(2646) : AC(776)
Diseases : Glaucoma : CK(371) : AC(86)
Pharmacological Actions : Neurogenesis : CK(215) : AC(109)
